prosthesis News
-
Showcase
The iFIT device gently and comfortably reshapes the residual limb.
This patient reduced their volume within a month period of time using the iFIT transtibial prosthesis. The iFIT system relieves swelling and shapes the limb quickly. There is no need to wait for prosthetic shrinker socks to reduce volume, so those with limb loss can be fit right away and get back on their feet. ...
-
Impact of Time to Receipt of Prosthesis on Total Healthcare Costs 12 Months Postamputation
Earlier receipt of a prosthesis is associated with reduced spending in the 12 months post-amputation of approximately $25,000 compared with not receiving a prosthesis. The results of this study suggest that not providing or delaying the provision of a prosthesis increases costs by about 25%. iFIT can help facilitate fitting patients soon after amputation with the ability to be fit anywhere ...
-
DT MedTech Assumes Production and Distribution of Hintermann Series Lower Extremity Medical Devices
DT MedTech, LLC (DTMT) announced today that on May 1, 2016, it will officially take over all production, sales, and worldwide distribution of the Hintermann Series lower extremity device product line. Developed by prominent surgeon, Prof. Beat Hintermann, the line includes: (1) Hintermann Series H3 3-piece Total Ankle Replacement prosthesis, including the Standard and Revision models (formerly ...
-
DT MedTech Secures CE Marking and Begins Active Distribution of Hintermann Series H3™ Lower Extremity Medical Devices
DT MedTech, LLC (DTMT) announced today that having secured CE Marking for the Hintermann Series H3 total ankle replacement devices, in compliance with mandatory European Directives, they are now actively selling and distributing their products outside the USA. The DTMT Hintermann Series products for the lower extremity include: (1) Hintermann Series H3 three-piece Total Ankle Replacement ...
-
Novostia Obtains EUR 2.5 Million Grant from the European Union To Support Its Heart Valve Technology
Neuchâtel, Switzerland, January 14, 2020 – Novostia announces that it has been awarded EUR 2.5 million grant from the European Union under the highly competitive Horizon 2020 EIC Accelerator. The EIC Accelerator is part of the European Innovation Council (EIC) pilot that supports top class companies with funding opportunities and acceleration services to help them develop and bring ...
By Novostia SA
-
DT MedTech Acquires Worldwide Ownership of Hintermann Series of Lower Extremity Replacement and Revision Medical Devices
DT MedTech, LLC (DTMT) announced today that it has successfully completed the acquisition of ownership of the Hintermann Series lower extremity device product line. Developed by prominent surgeon, Professor Beat Hintermann, this exceptional product line includes: (1) the Hintermann Series H3 3-piece Total Ankle Replacement prosthesis (formerly known as the HINTEGRA Total Ankle Replacement ...
-
reSept ASD Occluder implanted in EU for the first time
French TV France3 reported on the first patients implanted with a reSept ASD Occluder in France and in the European Union at Bordeaux University Hospital. The coverage includes video interviews with young patient Léo and his mother, and with the doctors that treated him, as part of the ASCENT ASD trial. Professor Jean-Benoît Thambo, head of the department of pediatric and congenital ...
-
DT MedTech Announces Successful Total Ankle Revision Procedures Using The New Hintermann Series H2 Tibial Assembly Component and PE Inlay
DT MedTech, LLC (DTM) announced today that their new Hintermann Series H2 Tibial Assembly component and PE inlay have been successfully implanted by Prof. Beat Hintermann in three patients needing total ankle revision surgery. World-renowned foot and ankle surgeon, Prof. Hintermann, developed the new, versatile, two-component, semi-constrained total ankle replacement prosthesis, Hintermann Series ...
-
Effects of prosthetic limb prescription on 3-year mortality among Veterans with lower-limb amputation
Method: Retrospective observational study on 4,578 Veterans hospitalized for LLA and discharged 2003- 2004, looking at time to all-cause mortality from the amputation surgical date up to the 3 yr anniversary. Results: 1,300 (28.4%) persons received a prescription for a prosthetic limb within 1 yr after the surgical amputation. About 46% (n = 2,086) of all Veterans w LLA died within 3 yr of the ...
-
CUSTOMFLEX® ARTIFICIALIRIS receives Transitional Pass‐through Payment Status
VEO Ophthalmics, LLC, today announced that the CUSTOMFLEX® ARTIFICIALIRIS has been approved by the Center for Medicare and Medicaid Services (CMS) for transitional pass‐through payment status, effective January 1, 2020. The HCPCS code for the CUSTOMFLEX® ARTIFICIALIRIS that is associated with pass‐through payment is: C1839 Iris prosthesis. The approval by CMS for transitional ...
-
ASTM F2083 - 11 Standard Specification for Total Knee Prosthesis
This specification covers total knee replacement (TKR) prostheses used to provide functioning articulation by employing femoral and tibial components, allowing a minimum of 110' of flexion to high flexion. Replaceable components of modular designs, for example, tibial articulating surfaces and all components labeled for or capable of being used with cement, regardless of ...
-
CARMAT receives FDA approval to use the new version of its artificial heart in the US Early Feasibility Study (EFS)
CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure, today provides an update on its early feasibility study (EFS) in the United States. The FDA has granted CARMAT approval to use the new ...
By Carmat
-
Novostia technology for heart valve prosthesis raises CHF 6.5 million to start first clinical trials
Neuchâtel, Switzerland, February 22, 2019 – Novostia announces that it raised CHF 6.5 million from private investors to advance its disruptive aortic and mitral heart valve to clinical trials. Heart valve diseases affect more than 100 million people worldwide. Every year hundreds of thousands of patients undergo a heart valve replacement. Available technologies entail serious ...
By Novostia SA
-
DT MedTech Announces Successful Implantations of the New Hintermann Series H2 Total Ankle Replacement Prosthesis
DT MedTech, LLC (DTM) announced today that Prof. Beat Hintermann, world-renowned foot and ankle surgeon and developer of the new, two-component, semi-constrained total ankle prosthesis, Hintermann Series H2 Total Ankle Replacement System, has successfully implanted five H2 devices in patients in Liestal, Switzerland. Four of the procedures were primary total ankle replacements and the fifth was a ...
-
Vilex Acquires DT MedTech and the Hintermann Series System Total Ankle Prostheses
Vilex, LLC, a member of the Squadron Capital family of businesses, announced today that it has successfully completed the acquisition of DT MedTech, LLC, whose product lines include the Hintermann Series System™ Total Ankle Replacement (TAR), developed by prominent surgeon, Professor Beat Hintermann. This exceptional TAR system includes the Hintermann Series H3 (H3) 3-piece, mobile-bearing ...
-
APrevent signed the distribution agreement in Lithuania
APrevent announced on 7TH December that APrevent and Labostera signed the distribution agreement for APrevent® VOIS in Lithuania. We are going to provide patients with glottic insufficiency/unilateral vocal fold paralysis an innovative, safe and effective surgical treatment. Labostera was founded in year 2005, they are experienced in ENT surgical products including surgical voice ...
-
ASTM F2091 - 01(2012) Standard Specification for Acetabular Prostheses
This specification covers acetabular resurfacing devices used to provide a functioning articulation between the bones of the acetabulum and the femur. Acetabular prostheses included within the scope of this specification are intended for mechanical fixation between the prosthesis and host bone, by the use of bone cement ...
-
VEO Ophthalmics Launches CUSTOMFLEX ARTIFICIALIRIS in the U.S.
VEO Ophthalmics, LLC, today announced the launch of the CUSTOMFLEX ® ARTIFICIALIRIS, the first iris prosthesis available in the United States. The surgically implanted device received FDA approval on May 30, 2018 for use in children and adults for the treatment of iris defects resulting from congenital aniridia, acquired defects or other conditions associated with a completely or partially ...
-
DT MedTech Announces 510(k) FDA Clearance for Hintermann Series H2 Total Ankle Replacement System
DT MedTech, LLC (DTM) today announced that the Hintermann Series H2 Total Ankle Replacement System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The Hintermann Series H2 is a semi-constrained, total ankle replacement prosthesis developed by Prof. Beat Hintermann, a world-renowned foot and ankle surgeon based in Liestal, Switzerland. The Hintermann Series H2 ...
-
VEO Ophthalmics Collaborates with The Masket Foundation for Rare Disease Day
VEO Ophthalmics, LLC announced today that, in honor of Rare Disease Day, it is collaborating with the Masket Foundation to raise awareness of aniridia and treatment options for aniridia. Aniridia is a serious ophthalmic rare disease in which a patient’s iris does not develop properly. VEO Ophthalmics is the U.S. distributor for the CUSTOMFLEX® ARTIFICIALIRIS, a custom-made artificial ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you